Advertisement
The leader in healthcare business news, research & data

Merrill Goozner

Editor Emeritus

Merrill Goozner served as Editor of Modern Healthcare from December 2012 to April 2017. As Editor Emeritus, he continues to write a weekly column, participate in Modern Healthcare education, events and awards programs and provide guidance on coverage related to healthcare transformation issues. Over the course of his four decades in journalism, he served as a foreign, national and chief economics correspondent for the Chicago Tribune and professor of journalism at New York University. He is the author of The $800 Million Pill: The Truth Behind the Cost of New Drugs (University of California Press, 2004), and has contributed articles to numerous publications. Goozner earned a master's degree in journalism from Columbia University and a bachelor's in history from the University of Cincinnati, where he received the Distinguished Alumni Award in 2008.

Editorial: More doom and gloom from the CMS


February 21, 2019

Over the past decade, CMS actuaries have consistently overestimated future healthcare spending. They failed to foresee the great moderation that in fact took place.

Editorial: The transparency trap


February 16, 2019

Among all the proffered panaceas for reducing America's high healthcare costs, price transparency is the least likely to make a major dent in the problem.

Editorial: The war on waste


February 01, 2019

Let's acknowledge that there's a tremendous amount of waste in the system. Unnecessary tests and procedures are performed every day in America's hospitals and physician offices.

Editorial: Left to their own devices


January 25, 2019

It's time for the relevant committees to tackle the regulation and prices of expensive and potentially dangerous medical devices, which are being inserted every day in thousands of patients in America's hospitals.

Editorial: How Trump's war on immigrants will harm healthcare


January 17, 2019

Rural communities will feel the pain first. But it will also ripple through major cities, where the healthcare workforce has become highly dependent on a steady stream of physicians, nurses and support staff born in other countries.

California's path to lower drug prices


January 08, 2019

Other populous states should take a close look at what California is doing. Smaller states may want to form compacts with their neighbors to pursue something similar. Gov. Gavin Newsom has offered a practical approach to achieving more reasonable drug pricing.

Advertisement
X

Subscribe and SAVE 50%

View our best offer
Subscribe to Print